PRESS RELEASE published on 01/26/2026 at 16:55, 7 months 17 days ago # UnionPay at Davos 2026: Showcasing China's Economic Resilience for a New Global Development Blueprint UnionPay showcased China's economic resilience at Davos 2026, emphasizing innovation, AI technology, global cooperation, and growth potential AI Technology China Economic Resilience UnionPay Davos 2026
PRESS RELEASE published on 01/26/2026 at 16:49, 7 months 17 days ago EQS-Adhoc: GEA Group Aktiengesellschaft: GEA Group AG releases preliminary financials 2025 GEA Group AG releases preliminary financials for 2025, with EBITDA margin of 16.5% exceeding guidance. Q4 order intake surpasses market expectations by 7% EBITDA Margin Order Intake GEA Group 2025 Preliminary Financials
PRESS RELEASE published on 01/26/2026 at 16:07, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. disclosed a 7.66% ownership position in American Axle & Manufacturing Holdings, Inc. on 23 January 2026 Disclosure Vanguard Group Financial Securities Ownership Position American Axle
PRESS RELEASE published on 01/26/2026 at 16:06, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% interest in JTC plc. Position disclosed on 23 January 2026 includes 8,758,406 shares of 1p ordinary class The Vanguard Group, Inc. 1p Ordinary JTC Plc 5.08% Interest 8,758,406 Shares
PRESS RELEASE published on 01/26/2026 at 16:06, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses a 4.89% interest in Glencore plc as of 23 Jan 2026. Additional disclosures include dealings in securities Securities Disclosure The Vanguard Group Dealings Glencore Plc
PRESS RELEASE published on 01/26/2026 at 16:05, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 6.02% interest in Avadel Pharmaceuticals plc's securities as of 23 Jan 2026. Purchase and sale transactions detailed in Form 8.3 Securities Vanguard Group Purchase And Sale Transactions Interest Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 01/26/2026 at 16:04, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% interest in Beazley plc. Purchase and sale of 5p ordinary shares detailed in Form 8.3 Form 8.3 Vanguard Group Beazley Plc 5.02% Interest Purchase Sale
PRESS RELEASE published on 01/26/2026 at 16:03, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.59% position in Spire Healthcare Group plc. Details include owning 14,446,914 relevant securities and recent purchase of 1p ordinary shares Position Disclosure Financial Dealings Vanguard Group Spire Healthcare 1p Ordinary Shares
PRESS RELEASE published on 01/26/2026 at 16:02, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.53% interest in Dowlais Group plc through Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Interests Disclosure Dowlais Group Plc
PRESS RELEASE published on 01/26/2026 at 16:01, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Auction Technology Group plc The Vanguard Group, Inc. discloses a 3.55% stake in Auction Technology Group plc with 4,297,980 shares. Purchase of 1,020 shares at 3.31 GBP each Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Auction Technology Group PLC
Published on 09/12/2026 at 02:35, 1 day 6 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 10 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 11 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 16 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 15 hours 29 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 1 hour ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 11 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 11 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 13 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 13 hours ago Availability of the 2026 Interim Financial Report
